IL17A and myasthenia gravis: Our study found that the plasma levels of IL-1β, IL-2, IL-4, IL-10, IL-17, TNF-α, IFN-α, and IFN-γ cytokines in GMG patients who were not treated with drugs were significantly higher than those in healthy controls, and the elevated cytokines reflected the immune activation status of MG.